Mostrar el registro sencillo del ítem

dc.contributor.authorPérez Robles, Raquel 
dc.contributor.authorFekete, Szabolcs
dc.contributor.authorKormány, Róbert
dc.contributor.authorNavas Iglesias, Natalia Africa 
dc.contributor.authorGuillarme, Davy
dc.date.accessioned2024-04-08T09:58:07Z
dc.date.available2024-04-08T09:58:07Z
dc.date.issued2024
dc.identifier.citationJournal of Chromatography A 1713 (2024) 464498 [10.1016/j.chroma.2023.464498]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/90479
dc.description.abstractWhen therapeutic proteins are analysed under hydrophilic interaction liquid chromatography (HILIC) conditions, there is an inherent mismatch between the sample diluent (proteins must be solubilised in aqueous media) and the mobile phase, which is mostly composed of aprotic solvent (acetonitrile). This difference in eluent strength between sample diluent and mobile phase is responsible for severe analyte breakthrough and peak distortion. As demonstrated with therapeutic proteins of different sizes (insulin of 6 kDa, anakinra of 17 kDa and rituximab subunits of 25 and 50 kDa), only very small volumes of 0.1–0.2 μL can be injected without breakthrough effects, when performing rapid analysis on short HILIC columns of 20–50 mm, leading to poor sensitivity. In order to avoid the undesired effect of the strong sample diluent, a special injection program should be preferred. This consists in the addition and automatic injection of a defined volume of weak solvent (acetonitrile) along with the sample to increase retention factors during sample loading. Various injection programs were tested, including the addition of a pre-injection or post-injection or both (bracketed injection) of acetonitrile plugs. Several weak to strong injection solvent ratios of 1:1, 1:2, 1:4 and 1:10 were tested. Our work proves that the addition of a pre-plug solvent with a weak vs. strong injection solvent ratio of 1:10 is a valuable strategy to inject relatively large volumes of proteins in HILIC, regardless of column dimensions, thus maximising sensitivity. No peak deformation or breakthrough was observed under these conditions. However, it is important to note that peak broadening (40 % larger peaks) was observed when the injection program increased the injection solvent ratio from 1:1 to 1:10. Finally, this strategy was applied to a wide range of therapeutic mAb products with different physico-chemical properties. In all cases, relatively large volumes can be successfully injected onto small volume HILIC columns using a purely aqueous sample diluent, as long as an appropriate (weak) solvent pre-injection is applied.es_ES
dc.description.sponsorshipJunta de Andalucía (ref: DOC_01694)es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectHydrophilic interaction liquid chromatographyes_ES
dc.subjectBreakthroughes_ES
dc.subjectSolvent mismatches_ES
dc.titleImproved sample introduction approach in hydrophilic interaction liquid chromatography to avoid breakthrough of proteinses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1016/j.chroma.2023.464498
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional